Search Results 1091-1100 of 21425 for anti-TNF drugs

1. Telmisartan (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Butalbital, Acetaminophen, Caffeine, And Codeine (Oral Route) Description and Brand Names - Mayo Clinic

   It has also been used for migraine headaches. Codeine belongs to the group of medicine called narcotic analgesics (pain medicines). It acts on the central ...

3. Estradiol (Transdermal Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Sucralfate (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Sulfonamide (Ophthalmic Route) Description and Brand Names - Mayo Clinic

   Sulfonamides, or sulfa medicines, belong to the family of medicines called anti-infectives. Sulfonamide ophthalmic preparations are used to treat infections ...

6. Liraglutide (Subcutaneous Route) Precautions - Mayo Clinic

   Other medicines—Do not take other medicines during the time you are using liraglutide unless they have been discussed with your doctor. This especially includes ...

7. Sodium Phenylacetate And Benzoate (Intravenous Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Ammonul. Descriptions. Sodium phenylacetate and benzoate ...

8. Use of weight-loss pharmacotherapy in patients with cirrhosis and in liver transplant recipients - Mayo Clinic

   More data is needed to establish the safety and efficacy of these agents in the pretransplant and post-transplant settings.

9. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

   Patients who have received infliximab, adalimumab or certolizumab pegol ≤ 8 weeks before the first administration of study drug; Patients with certain ...

10. Anticholinergics And Antispasmodics (Oral Route, Parenteral Route, Rectal Route, Transdermal Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...